Detalhe da pesquisa
1.
Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering.
Mol Pharm
; 15(3): 705-720, 2018 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28853901
2.
Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.
Chembiochem
; 18(13): 1204-1215, 2017 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28218815
3.
Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.
Glycoconj J
; 32(7): 425-41, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25931032
4.
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
Bioorg Med Chem Lett
; 25(6): 1223-7, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25690786
5.
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
ACS Chem Biol
; 18(1): 151-165, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626752
6.
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs.
Cells
; 10(2)2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33673061
7.
Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation Engineering.
Clin Transl Sci
; 14(1): 362-372, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064927
8.
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stability.
Bioorg Med Chem Lett
; 20(1): 387-91, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19919895
9.
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression.
Front Chem
; 8: 13, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32117864
10.
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.
Bioorg Med Chem Lett
; 19(17): 5004-8, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19646869
11.
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
Bioorg Med Chem Lett
; 19(20): 5931-5, 2009 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19736007
12.
Exploiting metabolic glycoengineering to advance healthcare.
Nat Rev Chem
; 3(10): 605-620, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777760
13.
Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production.
Biotechnol J
; 14(4): e1800186, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221828
14.
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.
Bioorg Med Chem Lett
; 18(9): 2830-5, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18430570
15.
Improving Immunotherapy Through Glycodesign.
Front Immunol
; 9: 2485, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450094
16.
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
PLoS One
; 13(5): e0195812, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29847599
17.
Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.
Biomaterials
; 116: 158-173, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926828
18.
Determination of absolute expression profiles using multiplexed miRNA analysis.
PLoS One
; 12(7): e0180988, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704432
19.
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells.
Oncotarget
; 7(41): 66491-66511, 2016 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27613843
20.
Cell Surface and Membrane Engineering: Emerging Technologies and Applications.
J Funct Biomater
; 6(2): 454-85, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096148